Clinicopathological characterization of duodenal adenocarcinoma with high CD44 variant 9 expression

[1]  J. Troelsen,et al.  Clinical implications of intestinal stem cell markers in colorectal cancer. , 2015, Clinical colorectal cancer.

[2]  M. Sugiyama,et al.  Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  M. Kasahara,et al.  Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis. , 2015, Experimental and molecular pathology.

[4]  M. Fukayama,et al.  Extra-ampullary Duodenal Adenocarcinoma , 2014, The American journal of surgical pathology.

[5]  M. Lisanti,et al.  Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer , 2014, Oncotarget.

[6]  S. Okazaki,et al.  Redox regulation in stem-like cancer cells by CD44 variant isoforms , 2013, Oncogene.

[7]  N. Ashley,et al.  Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. , 2013, Cancer research.

[8]  F. Gao,et al.  Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. , 2013, Gene.

[9]  T. Hibi,et al.  CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence , 2013, British Journal of Cancer.

[10]  T. Urano,et al.  CD44variant exon 9 plays an important role in colon cancer initiating cells , 2013, Oncotarget.

[11]  B. Aggarwal,et al.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. , 2012, Antioxidants & redox signaling.

[12]  J. Ji,et al.  Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Kun Yang,et al.  Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients , 2011, Cell Research.

[14]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[15]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[16]  L. Bourguignon,et al.  Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. , 2011, The American journal of pathology.

[17]  L. Terracciano,et al.  Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer , 2010, British Journal of Cancer.

[18]  Hans Clevers,et al.  OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. , 2009, Gastroenterology.

[19]  D. K. Lorance,et al.  Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[20]  S. Islam,et al.  Attributes of adult stem cells , 2009, The Journal of pathology.

[21]  P. Carter,et al.  CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers , 2008, British Journal of Cancer.

[22]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[23]  K. Konstantopoulos,et al.  Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells , 2006, Journal of Biological Chemistry.

[24]  H. Li,et al.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2006, Oncogene.

[25]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[26]  H. Okano,et al.  Function of RNA-binding protein Musashi-1 in stem cells. , 2005, Experimental cell research.

[27]  H. Saya,et al.  Mechanism and biological significance of CD44 cleavage , 2004, Cancer science.

[28]  Y. Guan,et al.  Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). , 2003, Blood.

[29]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[31]  M. Fujita,et al.  Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue. , 2000, Oral oncology.

[32]  J. Donohue,et al.  What prognostic factors are important in duodenal adenocarcinoma? , 2000, Archives of surgery.

[33]  L. Karnell,et al.  Adenocarcinoma of the small bowel , 1999 .

[34]  C. Eaves,et al.  Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. , 1999, Blood.

[35]  J. Fujimoto,et al.  Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression. , 1998, International journal of oncology.

[36]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[37]  Robert E. Brown,et al.  Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. , 2011, International journal of clinical and experimental pathology.

[38]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.